Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
January 24, 2020

Epizyme gets FDA approval for Tazverik to treat epithelioid sarcoma

Epizyme has secured accelerated approval from the US Food and Drug Administration (FDA) for its Tazverik (tazemetostat) to treat pateints epithelioid sarcoma.

Continue
The US FDA’s Centre for Drug Evaluation and Research (Credit: The U.S. Food and Drug Administration)
January 22, 2020

Eli Lilly to build $470m pharmaceutical manufacturing facility in North Carolina

Eli Lilly Corporate Centre, Indianapolis, Indiana, US (Credit: Momoneymoproblemz)
January 22, 2020

US reports first case of novel coronavirus from China-returned traveller

CDC confirms first case of novel coronavirus in the US. (Credit: James Gathany, Centers for Disease Control and Prevention)

Contracts

November 22, 2019

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

Image: ViiV Healthcare to develop investigational bNAbs. Photo: Courtesy of GlaxoSmithKline plc.

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

GeoVax, Leidos expand collaboration to malaria vaccines

Deals

Deals January 20, 2020

Clarivate Analytics to buy Decision Resources Group for $950m

Pharmaceutical Business Review

Merck wraps up $2.7bn acquisition of biopharmaceutical firm ArQule

Astellas, Adaptimmune sign deal to co-develop T-cell therapies for cancer

NeuroBo Pharmaceuticals and Gemphire Therapeutics complete merger

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

Innovative Fix-a-Form labels
Innovative Fix-a-Form labels
Pharmaceutical Business Review
Nitrosamine Risk Assessments are Due by April 2020 – Will You Comply?
Molnár-Institute to exhibit latest DryLab® software functionalities at PittCon in Chicago, USA
Molnár-Institute to exhibit latest DryLab® software functionalities at PittCon in Chicago, USA
How Denny Bros’ flag labels help healthcare professionals
How Denny Bros’ flag labels help healthcare professionals
German Health Authorities Grant LTS the Manufacturer’s Authorisation for Capsules
German Health Authorities Grant LTS the Manufacturer’s Authorisation for Capsules

Suppliers

Whitepapers

Words of Wisdom from Anders Vinther
Words of Wisdom from Anders Vinther
Modifications of Bio-Medical Staffs with High Magnetic Fields
Modifications of Bio-Medical Staffs with High Magnetic Fields
Nutrition Powder UV Sanitation
Nutrition Powder UV Sanitation